House Bill 127 Alabama 2026 Session

Summary

Primary Sponsor

Chip Brown Representative

Republican

Session

2026 Regular Session

Title

Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

Description

Existing law prohibits the State Board of Medical Examiners and the Medical Licensure Commission from taking action against the license of a physician when the physician recommends or prescribes a medical treatment that is off-label.

This bill would give pharmacists the same protection by prohibiting the Board of Pharmacy from suspending, revoking, or refusing to renew the license of a pharmacist who either recommends the off-label use of a drug or fills a prescription for the off-label use of a drug.

This bill would prohibit any entity that furnishes pharmacy services from terminating or taking adverse action against a pharmacist for recommending the off-label use of a drug or filling a prescription for the off-label use of a drug, and would provide a civil action for a pharmicist who is so terminated or disciplined.

This bill would prohibit a pharmacy benefits manager from taking any action against a pharmacist or his or her employing pharmacy in retaliation for recommending, or filling a prescription for, the off-label use of a drug.

This bill would also permit over-the-counter HB127 INTRODUCED sale of both Ivermectin and Hydroxychloroquine.

Show more Show less

Subjects

Occupational Licensing Boards